ClearPoint Neuro Inc vs Goodyear Tire & Rubber Co — how do they compare? ClearPoint Neuro Inc trades at $15.69 (market cap $478.63M), while Goodyear Tire & Rubber Co trades at $6.76 (market cap $1.91B). The key difference: Goodyear Tire & Rubber Co is far larger — about 4× ClearPoint Neuro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals.
| CLPT | GT | |
|---|---|---|
Market Cap | $478.63M | $1.91B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.60 | $11.54 |
52-Week Low | $8.66 | $5.58 |
Enterprise Value | $506.63M | $9.22B |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
Goodyear Tire & Rubber (GT) trades at $6.64, down 2.5% today, with a bearish technical signal and mixed quarterly earnings. The stock shows deep value metrics with a P/E of 4.69 and P/B of 0.64, but fundamental weakness persists with negative net income margin of -11.64% and ROE of -52.56%. Recent news includes a shift to the S&P SmallCap 600 and a $1.05 billion senior notes offering to strengthen liquidity.
The outlook remains challenging due to operational headwinds and declining revenue, though analyst consensus suggests 32% upside to the $8.75 price target. Key risks include sustained profitability issues and high debt, while potential catalysts include cost-saving initiatives and new contracts like NASA's lunar tire supply.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →